Bio-Techne Corp TECH

NAS: TECH | ISIN: US09073M1045 19/03/2025

60,89 USD (-3,09%)

(-3,09%) 19/03/2025

Grafiek Bio-Techne Corp

Grafiek Bio-Techne Corp

1 dag1d -3,09%
1 week1w 1,69%
1 maand1m -7,02%
3 maanden3m -16,78%
6 maanden6m -22,23%
1 jaar1j -15,29%
5 jaar5j 45,62%

Bio-Techne Corp in het nieuws

Toon enkel gratis nieuws

10 maart 2025 · Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System · Persbericht

3 maart 2025 · Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes · Persbericht

27 augustus 2024 · ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine · Persbericht

26 augustus 2024 · Bio-Techne To Present At Investor Healthcare Conferences · Persbericht

7 augustus 2024 · Bio-Techne Declares Dividend · Persbericht

7 augustus 2024 · Bio-Techne Releases Fourth Quarter Fiscal 2024 Results · Persbericht

31 juli 2024 · Bio-Techne Announces Next-Generation High Throughput Simple Western System · Persbericht

29 juli 2024 · Bio-Techne Announces Strategic Investment In Spear Bio · Persbericht

15 juli 2024 · Bio-Techne To Host Conference Call On August 7, 2024, To Announce Fourth Quarter And Fiscal 2024 Financial Results · Persbericht

31 mei 2024 · Bio-Techne To Present At Upcoming Investor Conferences · Persbericht

Profiel Bio-Techne Corp

Gezondheidstechnologie

Productie van biologische producten

Website: www.bio-techne.com

Hoofdzetel: Minneapolis, Minnesota Verenigde Staten

CEO: Charles Kummeth

Werknemers: 1.595

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe